Also, to further verify whether TRAF5 silencing could enhance HCC cell necroptosis by blocking NF-κB signaling, the NF-κB inhibitor SC75741 was administered to sh-TRAF5-transfected HepG2 cells. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.